# Pituitary Apoplexy Presenting With Oculomotor Nerve Palsy and Headache as the Initial Symptoms: A Case Report

**Authors:** Qifan Hou, Lixin Xu, Jing Yi

PMC · DOI: 10.1002/ccr3.70178 · Clinical Case Reports · 2025-02-07

## TL;DR

A 48-year-old patient presented with pituitary apoplexy, showing rare initial symptoms of oculomotor nerve palsy and headache, which improved after surgery and hormone treatment.

## Contribution

This case report highlights the rare initial presentation of pituitary apoplexy with oculomotor nerve palsy and headache.

## Key findings

- The patient's symptoms resolved after transnasal subtotal surgery and hormone therapy.
- Histopathology confirmed a pituitary adenoma with infarction.
- Early diagnosis and intervention are crucial for preserving pituitary function.

## Abstract

Pituitary apoplexy is a rare clinical syndrome. This report presents a case with initial symptoms of oculomotor nerve palsy and headache. A 48‐year‐old patient reported blurred vision in the right eye for 1 month, followed by a sudden onset of left eyelid ptosis and a 1‐day headache. Laboratory tests revealed normal pituitary function, except for an elevated growth hormone level (> 36.600 μg/L). Preoperative computed tomography (CT) and magnetic resonance imaging (MRI) scans indicated space‐occupying lesion in the sellar region. The lesion was subsequently resected via transnasal subtotal surgery. Histopathological and immunohistochemical analyses confirmed a pituitary adenoma with infarction. The patient received hydrocortisone preoperatively and prednisone and levothyroxine postoperatively. On the second postoperative day, the headache resolved, and the left eyelid regained normal function within 2 weeks. Pituitary apoplexy is extremely rare, with initial presentations of oculomotor nerve palsy being exceptionally uncommon. Early diagnosis and prompt surgical intervention are essential to preserve pituitary function and rapidly alleviate cranial nerve dysfunction.

## Linked entities

- **Chemicals:** hydrocortisone (PubChem CID 5754), prednisone (PubChem CID 5865), levothyroxine (PubChem CID 5819)
- **Diseases:** pituitary apoplexy (MONDO:0006908), pituitary adenoma (MONDO:0006373)

## Full-text entities

- **Genes:** GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}
- **Diseases:** infarction (MESH:D007238), eyelid ptosis (MESH:D001763), Pituitary Apoplexy (MESH:D010899), cranial nerve dysfunction (MESH:D003389), Headache (MESH:D006261), space-occupying lesion (MESH:D008158), pituitary adenoma (MESH:D010911), blurred vision (MESH:D014786), Oculomotor Nerve Palsy (MESH:D015840)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11805717/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11805717/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC11805717/full.md

---
Source: https://tomesphere.com/paper/PMC11805717